Device Survival Probability
D144VRC_D154VRC_SURV
| 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | at 137.0 mo | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % |  |
99.9 | 99.9 | 99.8 | 99.7 | 99.4 | 99.1 | 98.8 | 98.7 | 98.6 | 98.3 | 97.4 | 97.1 | |||||||||
| % |  |
99.4 | 99.0 | 98.7 | 98.2 | 97.2 | 91.5 | 84.1 | 75.3 | 59.9 | 35.9 | 13.3 | 5.2 | |||||||||
| # | 12605 | 11408 | 10198 | 8981 | 7899 | 6866 | 5846 | 4894 | 3535 | 1866 | 521 | 149 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Advisories For This Model
Performance Notes For This Model
- There are no performance notes for this model.
Product Characteristics
| Generator Type | ICD |
|---|---|
| NBD Code | VVE-VVIR |
| Max. Delivered Energy | 35 J |
| Connector Style | Cx Style |
|---|---|
| Serial Number Prefix | PNT |
| Mass | 68g |
| Volume | 35cc |
| Waveform | Biphasic |
| X-Ray ID | PNT |
Estimated Longevity
| Charging Frequency | 100% Pacing | 50% Pacing | 15% Pacing | 100% Sensing |
|---|---|---|---|---|
| Monthly | 4.8 | 5.0 | 5.2 | 5.3 |
| Quarterly | 7.5 | 8.3 | 8.8 | 9.0 |
| Semi-annual | 9.0 | 10.0 | 10.7 | 11.0 |
Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content
Distribution Data
| US Market Release | 2005-06-30 |
|---|---|
| CE Approval Date | 2005-02-04 |
| Registered USA Implants | 14465 |
| Estimated Active USA Implants | 976 |
| Normal Battery Depletions | 3165 |
| US Market Release | 2005-06-30 |
|---|---|
| CE Approval Date | 2005-02-04 |
| Estimated WW Distribution | 23649 |
| Normal Battery Depletions | 3429 |
Malfunctions (USA)
| Therapy Function Not Compromised | 102 |
|---|---|
| Battery | 19 |
| Electrical Component | 47 |
| Possible Early Battery Depletion | 24 |
| Other | 12 |
| Therapy Function Compromised | 50 |
| Battery | 19 |
| Electrical Component | 27 |
| Other | 4 |
Malfunctions (WW)
| Therapy Function Not Compromised | 144 |
|---|---|
| Battery | 21 |
| Electrical Component | 77 |
| Electrical Interconnect | 1 |
| Possible Early Battery Depletion | 30 |
| Software/Firmware | 1 |
| Other | 14 |
| Therapy Function Compromised | 62 |
| Battery | 23 |
| Electrical Component | 35 |
| Other | 4 |
EOS Indication
EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% VVI pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and six full-energy charges. EOL may be indicated before the end of three months if the device exceeds these conditions.
Recommended Replacement (RRT)
Battery voltage less than or equal to 2.61v.
Charge Time
D144VRC_D154VRC_CHRG
Data as of April 11, 2019